Familial hypercholesterolaemia
KEYWORDS: people, diagnosis, quality, statement, data, treatment, testing, clinical, children, specialist, hypercholesterolaemia, familial hypercholesterolaemia, clinical diagnosis, familial, source

cause FH. Methods should meet the standards set out by the UK Genetic Testing Network. Informed consent should be given for DNA testing. Quality statement 4: Diagnosis in children under 10 years Quality statement Children at risk of familial hypercholesterolaemia (FH) are offered diagnostic tests by the age of 10 years. Rationale Children with FH begin to develop cardiovascular disease before clinical signs appear, with thickening of the carotid artery wall identifiable by the age of 10 years. Diagnosis by the age of 10 years allows lifestyle changes and tailored therapy if indicated, which will reduce long-term problems associated with high cholesterol and improve long-term health. Quality measures The following measures can be used to assess the quality of care or service provision specified in the statement. They are examples of how the statement can be measured, and can be adapted and used flexibly. Structure Evidence of local arrangements to ensure that children at risk of FH are offered diagnostic tests by the age of 10 years. Data source: Local data collection. Process Proportion of children at risk of FH who receive a specified diagnostic test by the age of 10 years. Numerator â€“ The number of people in the
